buyWeak
Darin M Myman bought $8,651 of MYSE
Chief Executive Officer at Myseum, Inc.. 4,000 shares at an average of $2.16, traded Sep 19, 2025, filed Sep 19, 2025.
Conviction score
30Value
$8,651
4,000 shares
Holdings after
194,516
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$9k at market
- 0Relative to holdingsHoldings up 2.1%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying5 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001213900-25-089528, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 19, 2025 | POpen-market purchase Common Stock | +300 | $2.15 | $644 | 190,816 | Sep 19, 2025 |
| Sep 19, 2025 | POpen-market purchase Common Stock | +1,000 | $2.15 | $2,150 | 191,816 | Sep 19, 2025 |
| Sep 19, 2025 | POpen-market purchase Common Stock | +2,700 | $2.17 | $5,858 | 194,516 | Sep 19, 2025 |
Related signals
Other insiders at Myseum, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | MYSEbuy Myseum, Inc. | Darin M Myman Chief Executive Officer | $5,844 3,000 shares | +2% | |
| 30Weak | MYSEbuy Myseum, Inc. | Darin M Myman Chief Executive Officer | $5,970 3,000 shares | +2% | |
| 30Weak | MYSEbuy Myseum, Inc. | Darin M Myman Chief Executive Officer | $4,392 2,000 shares | +1% | |
| 25Weak | MYSEbuy Myseum, Inc. | Darin M Myman Chief Executive Officer | $12k 6,116 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.